Home Applications 220406 Application 220406
Type NDA
Sponsor AVYXA HOLDINGS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VYKOURA LEUCOVORIN CALCIUM SOLUTION;INTRAMUSCULAR, INTRAVENOUS EQ 50MG BASE/5ML (EQ 10MG BASE/ML) Yes Yes 002 VYKOURA LEUCOVORIN CALCIUM SOLUTION;INTRAMUSCULAR, INTRAVENOUS EQ 350MG BASE/35ML (EQ 10MG BASE/ML) Yes Yes 003 VYKOURA LEUCOVORIN CALCIUM SOLUTION;INTRAMUSCULAR, INTRAVENOUS EQ 500MG BASE/50ML (EQ 10MG BASE/ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N220406-001 VYKOURA LEUCOVORIN CALCIUM EQ 50MG BASE/5ML (EQ 10MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS RLD, RS 2026-02-03 N220406-002 VYKOURA LEUCOVORIN CALCIUM EQ 350MG BASE/35ML (EQ 10MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS RLD, RS 2026-02-03 N220406-003 VYKOURA LEUCOVORIN CALCIUM EQ 500MG BASE/50ML (EQ 10MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS RLD, RS 2026-02-03
Orange Book patents# Current patent rows page 1 of 1 · 3 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N220406-001 12564592 2044-12-23 Drug product 2026-03-05 N220406-002 12564592 2044-12-23 Drug product 2026-03-05 N220406-003 12564592 2044-12-23 Drug product 2026-03-05
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220406-001 VYKOURA EQ 50MG BASE/5ML (EQ 10MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS RLD, RS 2026-02-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220406-002 VYKOURA EQ 350MG BASE/35ML (EQ 10MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS RLD, RS 2026-02-03 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220406-003 VYKOURA EQ 500MG BASE/50ML (EQ 10MG BASE/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS RLD, RS 2026-02-03 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220406-001 12564592 2044-12-23 Drug product 2026-03-05 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220406-002 12564592 2044-12-23 Drug product 2026-03-05 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220406-003 12564592 2044-12-23 Drug product 2026-03-05 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join VYKOURA LEUCOVORIN CALCIUM Avyxa Pharma, LLC d122b875-435e-4e00-b945-7a0546df95c2 2026-03-12 Warnings, Adverse reactions Exact identifier application applno (NDA): 220406 application number: NDA220406
Documents# Document, Submission type, Date table Document Submission type Date 84940 ORIG 2026-02-05 84923 ORIG 2026-02-05